I n this issue of Circulation Research, Romani and colleagues 1 report that insulin stimulates uptake of ionized magnesium (Mg 2ϩ ) into heart. This study is the latest in a series by Romani, Scarpa, and colleagues regarding hormoneregulated Mg 2ϩ fluxes in heart and liver (References 1 and 2 and references therein). Over the past several decades, we have begun to uncover the mysteries of how cytosolic ionized calcium (Ca 2ϩ ) is regulated and how it regulates cell function. However, the more abundant divalent cation Mg 2ϩ still holds many secrets for us to unravel. Ca 2ϩ signaling is facilitated by the large Ca 2ϩ gradients (up to 10 000-fold) across the plasma and sarcoplasmic reticulum (SR) membranes. In contrast, only small gradients of Mg 2ϩ (generally a factor of 2 or less) are reported across the plasma or intracellular membranes. [3] [4] [5] In contrast to Ca 2ϩ signaling, agonists do not cause large (order of magnitude) alterations in cytosolic Mg 2ϩ . Even upon hormonal stimulation, of heart and liver, which results in a 10% to 15% change in total cell magnesium, there is little or no change in cytosolic Mg 2ϩ . This lack of change in cytosolic Mg 2ϩ has led many investigators to question whether Mg 2ϩ is involved in hormone signaling.
Is Intracellular Mg 2؉ Stable or Does It Function as an Intracellular Messenger?
Cytosolic Mg 2ϩ , which is regulated by plasma membrane and organelle transport, and by intracellular binding, is maintained far from electrochemical equilibrium. If cytosolic Mg 2ϩ were at electrochemical equilibrium, it would be Ϸ188 mmol/L, assuming a membrane potential of Ϫ70 mV and extracellular Mg 2ϩ of 1 mmol/L. Because the plasma membrane is not impermeable to Mg 2ϩ , there must be transport mechanisms to extrude Mg 2ϩ against its electrochemical gradient (for reviews, see . However, Mg 2ϩ permeability appears to be low and, therefore, Mg 2ϩ transporters may not require a high V max . Total cell magnesium would be in the range of 10 mmol/L if it were all free in the cytosol; however, as cytosolic Mg 2ϩ levels are reported to be 0.5 to 1 mmol/L, 3,9 -13 Ϸ90% to 95% of the cell magnesium is bound or sequestered. Ionized Mg 2ϩ levels in mitochondria are reported to be in the 0.5 to 1 mmol/L range, 4 and Mg 2ϩ levels in SR are reported to be 1 mmol/L 5 ;
therefore, most of the magnesium in the cell is bound, regardless of the precise location. Numerous enzymes and transporters are regulated by Mg 2ϩ . For example, Mg 2ϩ modulates Ca 2ϩ release from the SR, 14 alters the activity of many plasma membrane ion channels, [15] [16] [17] , influences Bax-induced release of cytochrome c and apoptosis, 18 and it has even been speculated that Mg 2ϩ may bind to the transcription factor DREAM and alter transcription. 19 There are a few reports suggesting small agonist-induced changes in cytosolic Mg 2ϩ 10, 12, 20 ; however, many studies report no agonist-induced changes in cytosolic Mg2ϩ. 8, 9, 11 In contrast to the lack of support for ␤-adrenergic agonistinduced change in cytosolic Mg 2ϩ , 8, 11 Romani et al 1 and Romani and Scarpa 2 and others 21, 22 have made the important observation that ␤-adrenergic agonists stimulate a large Mg2ϩ efflux from perfused heart and isolated myocytes. Approximately 10% to 15% of the total cellular magnesium is lost from the cell over 5 minutes. Activation of the ␤ 2 -adrenergic receptor has been shown to be primarily responsible for the stimulation of Mg 2ϩ efflux. 23 Additional studies by Romani et al 24 have shown that carbachol addition to heart enhances Mg 2ϩ uptake, leading to a 10% increase in total cell magnesium. These large changes in total cell magnesium occur with little or no change in cytosolic Mg 2ϩ , 8, 11 suggesting that the changes in total cell magnesium are due to changes in bound or sequestered magnesium. Furthermore, cytosolic Mg2ϩ is only 5% to 10% of the total cell magnesium, so the release of 10% to 15% of the total cell magnesium cannot be accounted for by a change in cytosolic Mg 2ϩ . How can the cell mobilize 10% to 15% of the total cell magnesium within minutes without a measurable change in cytosolic Mg 2ϩ ? It is clear that the change in total cell magnesium must be accompanied by a change in magnesium buffering in the cytosol or more likely in some organelle. There are two general scenarios by which ␤-adrenergic agonists can lead to a 10% to 15% release of Mg 2ϩ . In the first scenario (altered buffering), the ␤-adrenergic agonist alters magnesium buffering, causing a release of Mg 2ϩ , and the rate of release into the cytosol cannot exceed the maximum rate of efflux (V max ) across the plasma membrane. Thus, Mg 2ϩ exits from the cell without leading to a measurable increase in cytosolic Mg 2ϩ . Because most magnesium in intracellular organelles appears to be bound rather than in the ionized form, it is likely that if ␤-adrenergic agonists induce a release of Mg 2ϩ from an organelle, that this release would be secondary to altered magnesium buffering in that organelle. In this first scenario, the change in magnesium buffering is the primary event caused by the hormone, which is responsible for the change in total cell magnesium. In the second scenario (altered transport), the ␤-adrenergic agonist would increase plasma membrane Mg 2ϩ efflux, which must lead to at least a slight decrease in cytosolic Mg 2ϩ , which must be quickly balanced by a release of Mg 2ϩ from buffer sites or a release from intracellular organelles, which in turn must be due to a release from buffering sites. In the second scenario, the alteration in Mg 2ϩ transport is primary and the magnesium buffering quickly compensates.
Data suggest that intracellular organelles are the primary pool for the increase and decrease in cellular magnesium content observed after hormonal stimulation. ␤-Adrenergic agonists have been reported to cause an efflux of Mg 2ϩ from mitochondria. Addition of cAMP to mitochondria causes an efflux of Mg 2ϩ ,which is partially blocked by inhibitors of the adenine nucleotide translocator. 25 These data suggest that Mg 2ϩ release from the mitochondria is the primary event leading to ␤-agonist-or cAMP-stimulated Mg 2ϩ efflux from the cell. There are also several reports suggesting that altered magnesium buffering, often in intracellular organelles, is important for regulating magnesium homeostasis. If magnesium buffering were altered, this would be expected to alter uptake into the endoplasmic reticulum. Tetanus and caffeine, which also produce a large decrease in SR calcium, have been shown by electron probe microanalysis to cause a 50% increase in magnesium in the SR. 26 The Mg 2ϩ efflux measured after ␤-adrenergic stimulation is dependent on the Na ϩ gradient across the plasma membrane. Romani et al 24 reported that decreasing extracellular 24 This would be consistent with a calcium-induced alteration in magnesium buffering as a factor in Mg 2ϩ efflux. It is also interesting that the stimulation of Mg 2ϩ efflux with ␤-adrenergic agonists, as well as the stimulation of Mg 2ϩ uptake with carbachol, is not dependent on extracellular Mg 2ϩ over a wide range. 24 The carbachol-stimulated Mg 2ϩ uptake is similar whether the extracellular Mg 2ϩ is 2 mol/L or 50 mol/L or 1.2 mmol/L. This is most consistent with a role for magnesium buffering as the primary stimulus for the alteration in Mg 2ϩ transport. However, it is extremely surprising that the Mg 2ϩ uptake shows such a lack of dependence on extracellular Mg. This suggests an Mg 2ϩ uptake transporter with a very low K m . Taken together, the data suggest that alterations in Mg 2ϩ buffering are important for the hormonally induced changes in total cell magnesium. The observation that alterations in cell calcium (thapsigargin, Ca 2ϩ -free perfusion) alter Mg 2ϩ uptake and efflux suggests that alterations in buffering are important. In addition, the lack of dependence of Mg 2ϩ uptake or efflux on extracellular Mg 2ϩ would again support a role for altered magnesium buffering as being a major stimulus for ␤-adrenergic-and carbachol-induced altered cellular magnesium homeostasis. These data support a model in which alterations in magnesium buffering are the primary event driving altered magnesium homeostasis, although it is possible that hormonal stimulation could also alter Mg 2ϩ transporters at either the plasma membrane or organelle membranes. It is worth noting that Mg 2ϩ release from intracellular organelles is likely to be driven by alterations in magnesium buffering. Romani et al 1 have added to the mysteries of magnesium with a report that insulin also stimulates Mg 2ϩ accumulation in myocytes, but the intriguing new twist is that insulinstimulated Mg 2ϩ uptake is blocked if insulin-stimulated glucose transport is inhibited. It is possible that the increase in glucose transport and/or metabolism leads to altered magnesium buffering, and, therefore, if glucose transport is inhibited, Mg 2ϩ uptake is inhibited. However, Romani et al 1 also report in studies using isolated myocytes that glucose transport is inhibited when extracellular Mg 2ϩ is lowered below 25 mol/L. It is possible that the inhibition of glucose transport upon removing extracellular Mg 2ϩ is via a mechanism unrelated to the inhibition of Mg 2ϩ uptake by the removal of glucose. For example, it could be that extracellular Mg 2ϩ is necessary for the vesicle trafficking required for insulin stimulation of glucose transport by Glut4 translocation, whereas as discussed above, glucose transport could alter magnesium buffering and therefore be required for the insulin stimulation of Mg 2ϩ uptake. However, it is also possible that the inhibition of glucose transport with low extracellular Mg 2ϩ and the inhibition of Mg 2ϩ uptake in the absence of glucose are mechanistically related. It is interesting that ␤-adrenergic agonists, which also stimulate glucose uptake, enhance Mg 2ϩ efflux, in contrast to insulin, which enhances Mg 2ϩ uptake. Romani et al 1 suggest that this might be related to a difference in glucose transporters involved in the glucose uptake. Insulin stimulation of glucose transport is largely due to increased insertion of Glut4 into the plasma membrane. The mechanism responsible for ␤-adrenergicenhanced glucose uptake is less clearly understood but may involve stimulation of Glut1 rather than translocation of Glut4.
Limitations of the Methods

Measurements of Mg
2؉
Measurements of alterations in cytosolic Mg 2ϩ are more challenging than measurements of alterations in cytosolic Ca 2ϩ because although a 5-to 10-fold increase in cytosolic Ca 2ϩ is common, such a large percentage change in cytosolic Mg 2ϩ is unlikely because of the much higher basal cytosolic Mg . Atomic absorption spectroscopy measurements are also made of changes in total magnesium content in cells. However, if normal extracellular Mg 2ϩ is present, it must be washed away before measurement of magnesium content of the cells. Often, measurements of total cell magnesium are made in cells or hearts perfused nominally Mg 2ϩ -free. Also, the changes in total cell magnesium are Ϸ10%, which are only 2 to 3 times higher than typical biological errors. Romani et al 24 have confirmed many of their results using 28 Mg isotope, but this isotope has very limited availability.
The finding of hormone-induced Mg 2ϩ changes has not been observed by all investigators. Altschuld et al 32 reported that they could not repeat the studies showing norepinephrine-induced release of Mg 2ϩ from myocytes, nor did they detect a release of Mg 2ϩ from mitochondria treated with cAMP. Using mag-fura-2, they found no change in mitochondrial Mg 2ϩ on addition of cAMP. Also, they could not measure an increased uptake of Mg 2ϩ into myocytes treated with carbachol. Altschuld et al 32 did find that norepinephrine, in combination with low extracellular Mg 2ϩ , increased LDH release, which might account for the increase in Mg 2ϩ efflux with norepinephrine. However, as noted by the authors, an increase in damaged cells would not account for the increased Mg 2ϩ uptake observed with carbachol. The reasons for this discrepancy are unknown, but these conflicting results point out the importance of additional studies.
Unraveling the Mysteries
Future studies will be needed to determine whether the hormonally induced changes in total cell magnesium are important in agonist signaling and in regulating cell function. It is important to understand the physiological consequences of hormonally induced changes in magnesium homeostasis. What processes are regulated by these changes in total cell magnesium? An important related question for future research is determining whether these hormonally induced changes in total cell magnesium are accompanied by changes in Mg 2ϩ in a cell compartment or organelle. The activities of enzymes and transporters are altered by changes in Mg 2ϩ rather than total magnesium. The majority of data suggest that these hormonally induced changes in total cell magnesium are accompanied by little or no change in cytosolic Mg 2ϩ . However, it is likely that changes in magnesium buffering occur in intracellular organelles, and it is possible that changes in Mg 2ϩ occur in these organelles. Measurement of Mg 2ϩ in intracellular organelles is an important area for future research. This will require the development of more selective Mg 2ϩ indicators. It is also important to develop strategies to localize Mg 2ϩ selective indicators to intracellular organelles, as has been done for measurements of SR Ca 2ϩ . 33, 34 Another area for future research is to explore the mechanisms responsible for the hormonally induced changes in Mg 2ϩ transport and total magnesium content. Are changes in magnesium buffering primarily responsible for the altered magnesium homeostasis, or are there also changes in the activity of Mg 2ϩ transporters? There is a paucity of information regarding the Mg 2ϩ transporters. Lastly, although the data suggest that changes in buffering are important, we do not understand the mechanisms responsible for altered magnesium buffering.
In summary, the challenge for future research will be to elucidate whether agonist-induced alterations in Mg 2ϩ fluxes lead to physiological alterations in function. Within the next few years, we should begin to unravel some of the mysteries of magnesium.
